论文部分内容阅读
学术界和产业界分工明晰非常必要,只有这样科学家才可以做出更多、更好的基础研究成果,而产业界也可获知将如何更好地进行科研成果的产业转化。美国密歇根大学神经病学系的科学家们最近被一则消息所震惊:同事西德·吉尔曼被美国证券交易委员会起诉。起诉原因是西德·吉尔曼在担任药物临床试验安全委员会主席期间,曾向一名对冲基金分析师透露老年痴呆症新药临床试验的详细信息。而该分析师则利用这一内幕消息帮助一家公司在2008年夏天,获利2.76亿美元。这一事件再次掀起了人们对于学术界和产业
It is necessary that the division of labor between academia and industry be clear. Only in this way will scientists be able to make more and better basic research results, and industries will also be able to learn about how to better transform the industries of scientific research. Scientists at the University of Michigan Department of Neurology have recently been alarmed by a news that colleague Sid Gilman was sued by the U.S. Securities and Exchange Commission. The reason for the prosecution is that during the course of serving as Chairman of the Safety Committee of Drug Clinical Trials, West German Gilman once disclosed to a hedge fund analyst details of a clinical trial of a new drug for Alzheimer's disease. The analyst then used the inside story to help a company gain $ 276 million in the summer of 2008. This incident once again set off people for academia and industry